Project Number 5U01AG041140-04 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for GABA-A ALPHA-5 AGONISTS FOR THE TREATMENT OF AMNESTIC MILD COGNITIVE IMPAIRMENT Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-10-205: Alzheimer's Disease Drug Development Program (U01) FY Overall Cost $376,259 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
